Anagrelide and Mutational Status in Essential Thrombocythemia

被引：0
|
作者：
Alessandra Iurlo
Daniele Cattaneo
Nicola Orofino
Cristina Bucelli
Sonia Fabris
Agostino Cortelezzi
机构：
[1] IRCCS Ca’ Granda–Maggiore Policlinico Hospital Foundation and University of Milan,Oncohematology Division
[2] IRCCS Ca’ Granda–Maggiore Policlinico Hospital Foundation,Oncohematology Unit of the Elderly
来源：
BioDrugs | 2016年 / 30卷
关键词：
Mutational Status; Hydroxyurea; Essential Thrombocythemia; JAK2V617F Mutation; Platelet Response;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：219 / 223
页数：4
相关论文
共 50 条
  • [1] Anagrelide and Mutational Status in Essential Thrombocythemia
    Iurlo, Alessandra
    Cattaneo, Daniele
    Orofino, Nicola
    Bucelli, Cristina
    Fabris, Sonia
    Cortelezzi, Agostino
    [J]. BIODRUGS, 2016, 30 (03) : 219 - 223
  • [2] Anagrelide for essential thrombocythemia
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 1997, 39 (1016): : 120 - 120
  • [3] Treatment of essential thrombocythemia with anagrelide
    Silverstein, MN
    Tefferi, A
    [J]. SEMINARS IN HEMATOLOGY, 1999, 36 (01) : 23 - 25
  • [4] TREATMENT OF ESSENTIAL THROMBOCYTHEMIA WITH ANAGRELIDE
    CHINTAGUMPALA, MM
    KENNEDY, LL
    STEUBER, CP
    [J]. JOURNAL OF PEDIATRICS, 1995, 127 (03): : 495 - 498
  • [5] Anagrelide hydrochloride for essential thrombocythemia
    Besses, Carles
    [J]. EXPERT OPINION ON ORPHAN DRUGS, 2013, 1 (12): : 1049 - 1062
  • [6] Anagrelide in essential thrombocythemia (ET)
    Peraino, M
    Bizzoni, L
    Bernasconi, S
    Spadea, A
    Russo, D
    Cervellera, M
    Mazzucconi, MG
    [J]. THROMBOSIS RESEARCH, 1998, 91 (03) : S25 - S26
  • [7] ESSENTIAL THROMBOCYTHEMIA IN A CHILD - MANAGEMENT WITH ANAGRELIDE
    CHINTAGUMPALA, MM
    STEUBER, CP
    MAHONEY, DH
    OGDEN, AK
    FERNBACH, DJ
    [J]. AMERICAN JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1991, 13 (01): : 52 - 56
  • [8] Successful treatment of essential thrombocythemia with anagrelide in a child
    Hermann, J
    Fuchs, D
    Sauerbrey, A
    Hempel, L
    Zintl, F
    [J]. MEDICAL AND PEDIATRIC ONCOLOGY, 1998, 30 (06): : 367 - 370
  • [9] Efficacy and safety of anagrelide in childhood essential thrombocythemia
    Kanai, Ayako
    Morokawa, Hirokazu
    Matsuda, Kazuyuki
    Shimazaki, Ei
    Nakazawa, Yozo
    [J]. PEDIATRICS INTERNATIONAL, 2017, 59 (09) : 1017 - 1018
  • [10] Relevance of JAK2 mutational status in essential thrombocythemia
    Marino, A.
    Martino, B.
    Ronco, F.
    Ianni, G.
    C, Mammi
    Alati, C.
    C, Lagana
    Bianca, O.
    Nobile, F.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 166 - 166
12345